相关实验视频
Updated: May 27, 2025

Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
扩散型大B细胞淋巴瘤 (DLBCL):流行病学,病理生理学,风险分层,诊断方法和前景的进步:叙事性审查
Ayenew Berhan1, Andargachew Almaw2, Shewaneh Damtie2
1Department of Medical Laboratory Science, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia. ayenewbirhan10@gmail.com.
扩散性大B细胞淋巴瘤 (DLBCL) 是一种侵袭性癌症. 先进的诊断技术正在改善患者分层和对这种异质性疾病的理解.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 扩散性大B细胞淋巴瘤 (DLBCL) 是一种侵略性的非霍奇金淋巴瘤,占全球病例的约40%.
- DLBCL是一种异质性疾病,具有明显的病理,临床和分子亚型,通常按起源细胞分类.
- 发病率随着年龄的增长而增加,国际预后指数对于风险分层至关重要.
研究的目的:
- 审查扩散型大B细胞淋巴瘤的病理生理学,流行病学和诊断方面的进展.
- 突出新兴技术在DLBCL诊断和结果预测中的作用.
主要方法:
- 关于DLBCL的当前文献的审查.
- 讨论诊断技术,包括切除活检,免疫组织化学,下一代测序和基于数组的比较杂交.
主要成果:
- DLBCL亚型通过基因表达特征进行区分,例如生殖中心和激活的B细胞类.
- 先进的技术有助于识别基因变异,尽管临床验证仍在进行中.
- 国际预后指数仍然是疾病分层的一个关键工具.
结论:
- 诊断和管理DLBCL从了解其异质性质中受益.
- 先进的分子和遗传技术显示出改善DLBCL诊断和患者结果评估的希望.
- 进一步验证新的诊断工具对于临床整合至关重要.
更多相关视频
15:07VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
Published on: December 28, 2015
09:02Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
相关概念视频
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...